Revere Pharmaceuticals is a Boston-based startup leading the way in the development of new cancer treatments targeting Rac1 GTPase, an important target in the progression of different cancers. R-ketorolac, our lead candidate, is a first-in-class Rac1 inhibitor that shows both clinical and non-clinical evidence of efficacy in ovarian cancer.
Location: United States, Massachusetts, Arlington
Member count: 1-10
Total raised: $1.1M
Founded date: 2016
Investors 1
| Date | Name | Website |
| - | XLerateHea... | xleratehea... |
Funding Rounds 1
| Date | Series | Amount | Investors | Deal News |
| 31.08.2021 | - | $1.1M | - | - |